Skip to content

ZMACK-FACE

Active
Private limited companyfounded 2024active for 1 yearHarmoniestraat 68, 2018 Antwerpen, Belgium21 active companies are registered at this addressKBO/BCE: BE 1015.754.801
Summary

ZMACK-FACE has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €46,290 and a net result of €50,174. Its solvency ranks better than 26% of 20,330 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
€148,724total assets 2025
Equity
€46,290
Profit
€50,174
Turnover not published (micro format)
Financial health
94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
Parent
ZMACK · 100%
Accounts 50 days early0 of 1 deed read
Why 94raises riskFounded in 2024lowers riskSector: Human health activities (NACE 86)Size: total assets €148,724Figures for financial year 2025 (filed 11-06-2026)Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 53% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency 56+35
equity 31.1% of total assets
Liquidity 30-20
short-term debt 68.9% · cash 13.1%
Profitability 100+94
return on assets 33.7%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,042 companies, NACE 86, micro)
Last 24 months 11-2025: 0.1% 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026highest value 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026lowest value 09-2026: 0.1%● unchanged vs 08-2026lowest value 10-2026: 0.1%● unchanged vs 09-2026
Credit of up to €4,000 on 30-day terms is acceptable
Liquidity tight (current ratio 1.31, compared with 0.79 in 2024, below the usual 1.5; short-term debt: 68.9% and cash: 13.1% of total assets), and 68.9% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 27% on solvency, 5% on liquidity, 80% on profitability and 99% on growth.

The bankruptcy probability was computed on 12-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Founded in 2024
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Size: total assets €148,724
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 11-06-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 11-06-2026, 50 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
50 days early
2024
42 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 2 accounts on average 46 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
13-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2024.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Back to profitnet €50,174
  3. Annual accounts filedfinancial year 2024 · micro…

Key points

  • Positive: Back in profit in 2025after -€8,884 in 2024 €50,174 View
  • Controlled by ZMACK 100% View
  • Total assets 20252 financial years filed €148,724 View

By topic

Financials

Financial year
2025
Total assets
€148,724
Profit
€50,174
Solvency
31.1%
Total assets▲ 64.5%
Net result
20242025
Go to Financials

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
30-10-2024
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.